Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11119-e11119
Open Access | Times Cited: 19

Showing 19 citing articles:

Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
Xinyu Li, Maozhang He, Xinrui Yi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26991-e26991
Open Access | Times Cited: 15
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis
María Mercado-Gómez, Naroa Goikoetxea‐Usandizaga, Annarein Kerbert, et al.
Metabolism (2024) Vol. 158, pp. 155952-155952
Closed Access | Times Cited: 8
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
Alfredo Smiriglia, Nicla Lorito, Marina Serra, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108363-108363
Open Access | Times Cited: 13
Deciphering the role of Dietary Modifications and Gut Dysbiosis in Non-Alcoholic Fatty Liver Disease
Meenakshi Vachher, Kamaljeet Kaur, Manisha Mahrotra, et al.
Human Nutrition & Metabolism (2025), pp. 200305-200305
Open Access
Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment
Yijing Li, Lijie Li, Yishuo Zhang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
Carbon metabolism in the regulation of macrophage functions
Zhending Gan, Muyang Zhao, Yaoyao Xia, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 1, pp. 62-73
Closed Access | Times Cited: 10
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 9
Mechanisms of Epigenetic Regulation in the Fibrogenic Activation of Hepatic Stellate Cells in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Gene Expression (2024) Vol. 23, Iss. 1, pp. 31-43
Open Access | Times Cited: 3
Metabolomics at the cutting edge of risk prediction of MASLD
En Ying Tan, Mark Muthiah, Arun J. Sanyal
Cell Reports Medicine (2024), pp. 101853-101853
Closed Access | Times Cited: 2
Functional Genomics and Network Biology
Amit Joshi, Ajay Kumar, Vikas Kaushik
Advances in Bioinformatics (2024), pp. 71-96
Closed Access | Times Cited: 2
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Pinggui Chen, Yaoxuan Li, Yunyan Dai, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 581-594
Open Access | Times Cited: 2
Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and Cholestophagy
Claudia Theys, Joe Ibrahim, Ligia Mateiu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16412-16412
Open Access | Times Cited: 5
Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis
Hanqi Bi, Bing Zhou, Jialin Yang, et al.
Life Sciences (2023) Vol. 329, pp. 121951-121951
Closed Access | Times Cited: 4
The relationship between folic acid and nonalcoholic fatty liver disease
Bing'er Xu, Xinyu Yang, Xiaopeng Zhu, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies
Sathish Kumar Mungamuri, Yogendra Kumar Gupta, Padaki Nagaraja Rao, et al.
Gene Expression (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 3
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
Xu Li, Yuhong Fan, Xiao‐Jing Zhang, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 703-715
Open Access
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease
А.Е. Абатуров, Anna Nikulina, О.О. Русакова
CHILD`S HEALTH (2024) Vol. 19, Iss. 4, pp. 230-242
Open Access
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency
Ivan Tattoli, Aimee Rachel Mathew, Antonella Verrienti, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1631-1631
Open Access
Page 1

Scroll to top